Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

BVMF/R1MD34 stock hub

BVMF/R1MD34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/R1MD34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

146.9B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/R1MD34

In the news

Latest news · BVMF/R1MD34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.3

P25 11.3P50 14.6P75 19.6

Trailing P/E18.5

P25 15.2P50 21.5P75 27.3

ROE25.2

P25 5.3P50 12.3P75 22.5

ROIC26.9

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/R1MD34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	10,600
Employees Change	620%
Employees Change Percent	6.21
Enterprise value	BRL 142.9B
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Last refreshed	2026-05-10
Market cap	BRL 146.9B
Price	BRL 259
Price currency	BRL
Rev Per Employee	2,725,388.9x
Sector	Healthcare
Sic	3845
Symbol	bvmf/R1MD34
Website	https://www.resmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.4%
EV Earnings	18.02x
EV/EBIT	15.11x
EV/EBITDA	13.49x
EV/FCF	15.61x
EV/Sales	5.27x
FCF yield	6.23%
Forward P/E	17.33x
P/B ratio	4.34x
P/E ratio	18.53x
P/S ratio	5.08x
PE Ratio10 Y	38.74x
PE Ratio3 Y	27.5x
PE Ratio5 Y	37.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.76%
EBITDA Margin	38.27%
FCF margin	31.68%
Gross margin	62.18%
Gross Profit	BRL 18B
Gross Profit Growth	15.51%
Gross Profit Growth Q	16.15%
Gross Profit Growth3 Y	14.58%
Gross Profit Growth5 Y	13.24%
Net Income	BRL 7.9B
Net Income Growth	15.71%
Net Income Growth Q	9.23%
Net Income Growth3 Y	20.76%
Net Income Growth5 Y	27.15%
Pretax Margin	34.37%
Profit Margin	27.44%
Profit Per Employee	BRL 747,845
ROA	14.72
Roa5y	12.79
ROCE	25.9
ROE	25.25
Roe5y	23.02
ROIC	26.9
Roic5y	20.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-22.04%
Cagr3y	-2.82%
Cagr5y	0.66%
Div CAGR3	11.41%
Div CAGR5	8.56%
EPS Growth	16.39
EPS Growth Q	10.48
EPS Growth3 Y	20.96
EPS Growth5 Y	27.08
FCF Growth	11.82%
FCF Growth Q	-6.7%
FCF Growth3 Y	60.86%
FCF Growth5 Y	18.6%
OCF Growth	14.34%
OCF Growth Q	-4.24%
OCF Growth10 Y	14.12%
OCF Growth3 Y	52.27%
OCF Growth5 Y	17.59%
Revenue Growth	10.28x
Revenue Growth Q	10.81x
Revenue Growth3 Y	11.31x
Revenue Growth5 Y	12.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.68
Assets	BRL 45.8B
Cash	BRL 8.7B
Current Assets	BRL 20B
Current Liabilities	BRL 6.6B
Debt	BRL 4.4B
Debt EBITDA	BRL 0.39
Debt Equity	BRL 0.13
Debt FCF	BRL 0.48
Equity	BRL 33.9B
Liabilities	BRL 12B
Long Term Assets	BRL 25.9B
Long Term Liabilities	BRL 5.3B
Net Cash	BRL 4.3B
Net Cash By Market Cap	BRL 2.9
Net Cash Growth	779.44%
Net Debt EBITDA	BRL -0.39
Net Debt Equity	BRL -0.13
Net Debt FCF	BRL -0.47
Tangible Book Value	BRL 15.8B
Tangible Book Value Per Share	BRL 109
WACC	9.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.01
Inventory Turnover	2.24
Net Working Capital	BRL 7B
Quick ratio	2
Working Capital	BRL 14.2B
Working Capital Turnover	BRL 11.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.62%
Dividend Growth	7.38%
Dividend Growth Years	6%
Dividend per share	BRL 2.13
Dividend Years	7
Dividend Yield	0.82%
Ex Div Date	2026-02-11
Last Dividend	BRL 0.53
Payout Frequency	Quarterly
Payout Ratio	22.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-22.03%
200-day SMA	312
3Y total return	-8.23%
50-day SMA	339.5
50-day SMA vs 200-day SMA	50over200
5Y total return	3.33%
All Time High	397
All Time High Change	-34.76%
All Time High Date	2025-08-22
All Time Low	139.3
All Time Low Change	85.9%
All Time Low Date	2020-03-20
ATR	10.1
Beta	0.93
Ch YTD	-22.53
High	259
High52	397
High52 Date	2025-08-22
High52ch	-34.76%
Low	259
Low52	253
Low52 Date	2026-05-08
Low52ch	0%
Ma50ch	-23.71%
Price vs 200-day SMA	-16.99%
RSI	27.34
RSI Monthly	36.09
RSI Weekly	35.93
Sharpe ratio	0.35x
Sortino ratio	0.59
Total Return	1.44%
Tr YTD	-22.42
Tr1m	-10.6%
Tr3m	-22.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 10B
Operating Income Growth	19.41
Operating Income Growth Q	18.63
Operating Income Growth3 Y	19.68
Operating Income Growth5 Y	16.44
Operating margin	34.76

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	144,169,809%
Net Borrowing	-49,142,000
Shares Insiders	0.52%
Shares Institutions	76.08%
Shares Qo Q	-0.44%
Shares Yo Y	-0.62%
Short Ratio	10.14

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 8.6B
Average Volume	21.7x
Bv Per Share	233.5
CAPEX	BRL -708.1M
Ch1m	-10.6
Ch1y	-22.5
Ch3m	-22.35
Ch3y	-10.06
Ch5y	0.39
Ch6m	-21.19
Change	0%
Change From Open	0
Depreciation Amortization	956,421,260.8
Dollar Volume	8,547.3
Earnings Date	2026-04-30
EBIT	BRL 10B
EBITDA	BRL 11.1B
EPS	BRL 54.1
F Score	6
FCF	BRL 9.2B
FCF EV Yield	6.4x
Financing CF	-4,735,492,552
Fiscal Year End	June
Founded	1,989
Goodwill	14,954,578,931.2
Graham Number	137.04561
Graham Upside	-47.09
Income Tax	BRL 2B
Investing CF	-1,540,295,440
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	BRL 349
Lynch Upside	34.92
Ma150	333
Ma150ch	-22.22%
Ma20	310.3
Ma20ch	-16.54%
Net CF	3,796,742,888
Next Earnings Date	2026-07-30
Open	259
P FCF Ratio	16.05
P OCF Ratio	14.9
Payment Date	2026-03-20
Ppne	3,580,358,350.8
Price Date	2026-05-04
Price EBITDA	BRL 13.28
Ptbv Ratio	9.31
Relative Volume	1.55x
Revenue	28,889,122,321x
SBC By Revenue	1.84x
Share Based Comp	530,233,146
Tax By Revenue	6.93x
Tax Rate	20.16%
Tr6m	-20.94%
Volume	33
Z Score	12.56

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/R1MD34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$2.13 annual per share

Payout ratio

+22.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+8.6%

6 consecutive years of growth

Total shareholder yield

+1.4%

Next ex-dividend date: 2026-02-11

Performance

BVMF/R1MD34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/R1MD34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+76.1%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/R1MD34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

27.3

Below 30: short-term oversold

Price vs 200-day MA

-17.0%

50/200-day relationship not available

Beta (5Y)

0.93

Moves roughly with the market

Sharpe ratio

0.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/R1MD34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/R1MD34 stock rating?

bvmf/R1MD34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/R1MD34 analysis?

The full report lives at /stocks/bvmf/R1MD34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/R1MD34?

The latest report frames bvmf/R1MD34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/R1MD34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.